Jazz Pharmaceuticals plc buy Piper Sandler
Start price
20.03.24
/
50%
€115.05
Target price
20.03.25
€173.30
Performance (%)
-10.65%
Price
26.07.24
€102.80
Summary
This prediction is currently active. The price of Jazz Pharmaceuticals plc has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.65%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 2.646% | 2.646% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Piper_Sandler for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Piper Sandler from $171.00 to $188.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat